ARHGDIB and inflammatory bowel disease: Though not related to its function, it is worth mentioning that RhoGDI2 was recently identified as an extremely sensitive fecal biomarker to quantify gut inflammation in patients with inflammatory bowel disease (IBD) to estimate IBD severity [65].